- Home
- SBFM vs SSY Comparison
SBFM vs SSY Comparison
Compare SBFM & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- SSY
- Stock Information
- Founded
- SBFM 2006
- SSY 1959
- Country
- SBFM United States
- SSY United States
- Employees
- SBFM N/A
- SSY N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- SBFM Health Care
- SSY Health Care
- Exchange
- SBFM Nasdaq
- SSY Nasdaq
- Market Cap
- SBFM 3.7M
- SSY 5.7M
- IPO Year
- SBFM N/A
- SSY N/A
- Fundamental
- Price
- SBFM $3.00
- SSY $0.80
- Analyst Decision
- SBFM
- SSY
- Analyst Count
- SBFM 0
- SSY 0
- Target Price
- SBFM N/A
- SSY N/A
- AVG Volume (30 Days)
- SBFM 153.8K
- SSY 9.3K
- Earning Date
- SBFM 11-11-2024
- SSY 11-15-2024
- Dividend Yield
- SBFM N/A
- SSY N/A
- EPS Growth
- SBFM N/A
- SSY N/A
- EPS
- SBFM N/A
- SSY N/A
- Revenue
- SBFM $30,481,982.00
- SSY $32,439,999.00
- Revenue This Year
- SBFM $86.70
- SSY N/A
- Revenue Next Year
- SBFM $126.76
- SSY N/A
- P/E Ratio
- SBFM N/A
- SSY N/A
- Revenue Growth
- SBFM 109.82
- SSY N/A
- 52 Week Low
- SBFM $2.42
- SSY $0.53
- 52 Week High
- SBFM $660.00
- SSY $1.05
- Technical
- Relative Strength Index (RSI)
- SBFM 46.45
- SSY 48.97
- Support Level
- SBFM $2.85
- SSY $0.78
- Resistance Level
- SBFM $3.05
- SSY $0.85
- Average True Range (ATR)
- SBFM 0.15
- SSY 0.03
- MACD
- SBFM 0.02
- SSY -0.00
- Stochastic Oscillator
- SBFM 43.59
- SSY 24.00
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operates nearly 80-licensed-bed, acute care hospitals, which includes more than 18-bed geriatric psychology unit, and over 60-bed nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.